Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Jason Butler’s rating is based on the promising results of Viridian Therapeutics’ Phase 3 THRIVE-2 trial, which ...

As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Tempus AI (TEM) with an Outperform rating and $60 price target Tempus AI, a diagnostic company that has built a broad ...

The UNLV football team is led by an impressive group of seniors that could be replaced next season by what multiple ranking ...

Qatar Airways' tasty food, extensive drinks list, and friendly crew made the flight feel luxurious — not to mention the comfy suite and sliding door.